In the metastasis sub-cohorts, the high expression of IL-33 is associated with more infiltrations of CD8+ T cells, NK cells and DCs in tumor samples, and these immune components have been proven to be important mediators of the anti-tumor effects of IL-33 in mouse melanoma models [9–11]. Here, CD8A is linked to melanoma.